Board of Directors

 

William J. Golden, CFA

Executive Chairman

Mr. Golden is a co-founder and Executive Vice President of Stemnion.  Prior to Stemnion, he co-founded Lancet Capital, a biomedical early stage venture capital fund, which is the seed investor in Stemnion. Prior to co-founding Lancet Capital, he served as Director of the Community Technology Fund, an early stage venture capital fund affiliated with the Boston Medical Center and Boston University. Mr. Golden has an MBA from Harvard Business School and a Bachelor of Science in mechanical engineering from the University of Notre Dame.

 

John H. McArthur

Independent Director

Mr. McArthur brings more than 40 years of experience with healthcare and technology companies. He has served on the boards of GlaxoSmithKline plc; HCA Inc.; Teradyne Inc.; Rohm & Haas, Data General Co., Duke University Health Systems. Following the affiliation of Brigham and Women's and Massachusetts General Hospital, he was founding co-chair of the Board of Trustees of Partners HealthCare System, Inc. He currently chairs the Center for Surgery and Public Health at the Brigham and Women's Hospital in Boston. Mr. McArthur was Dean of the Faculty at Harvard Business School from 1980-1995. He has held numerous corporate directorships, committee memberships and consulting posts at companies including Arvida Corporation, Chase Manhattan Corporation, Cabot Corporation and Bell Canada. From 1996 to 2005 he served as  Senior Advisor to the President of The World Bank.

 

Donald J. Wagner, Sr.

Independent Director

Mr. Wagner is a member of the board of directors of the American Diabetes Association. He founded Cycam, Inc. (MedSource Technologies) as a medical components supplier to major medical products companies.  In past years, he has worked for Pfizer Pharmaceutical, TriState Machinery Co., Sweco, Inc., and Dynamet, Inc. as a CEO, general manager and vice president of sales and marketing.  These positions involved medical products, material science, research and development and intellectual property.  Mr. Wagner graduated from Gannon University with a degree in Marketing/Management.

 

Terence C. Golden

Independent Director

Mr. Golden is Chairman of Bailey Capital Corporation, an investment company. He chairs the Federal City Council in Washington D.C., a non–profit organization and has served as President/CEO of Host Marriott Corp., Asst. Secretary of the Treasury and Administrator of the General Services Administration.  He was co-founder and national managing partner of Trammell Crow Residential Companies.  Mr. Golden is a director of Host Marriott Corp., Pepco Holdings, Inc. (PHI) and The Morris and Gwendolyn Cafritz Foundation.  He has a BA from the U. of Notre Dame, an M.S. from MIT, and an MBA from Harvard Business School.

 

George L. Sing

Mr. Sing is a co-founder and CEO of Stemnion. Prior to Stemnion, he co-founded Lancet Capital, a biomedical early stage venture capital fund which is the seed investor in Stemnion. Mr. Sing has served executive operating roles in several technology-based companies as well as board director of both private and public companies, and currently is a director of Regeneron Pharmaceuticals, Inc. He was co-founding Partner of Advanced Technology Ventures and Merrill Lynch Venture Capital, Inc. Mr. Sing has an MBA from the Harvard Business School and a Bachelor of Engineering from Stevens Institute of Technology.